Mariana Socal

Alan Weil interviews Mariana Socal on the global supply chain for generic drugs. They discuss the heavy reliance and lack of competition in the market, the role of active pharmaceutical ingredients in the supply, the vulnerability and potential disruptions in drug production, the limited number of producers in the global supply chain, and the competition and vulnerability in the US market. They highlight the need for better monitoring and inspection for international sources to ensure quality and functionality in the generics market.

The podcast delves into the FDA's decision to allow Florida to import drugs from Canada and discusses the differences in drug prices between the US and Canada. It also explores ethical dilemmas in global markets, the importance of transparency in drug pricing, and cybersecurity preparedness for finance leaders.